Fragile X Syndrome: A Comprehensive Review of Etiology, Pathophysiology, and Management
Shagufta Naz, A and Snigdha, Bairagi and Ramya, A (2026) Fragile X Syndrome: A Comprehensive Review of Etiology, Pathophysiology, and Management. In: Innovations in Pharmaceutical Therapeutics and Drug Delivery. SCIENTIFIC RESEARCH REPORTS, pp. 85-92. ISBN 978-81-685538-8-0
Fragile X Syndrome A Comprehensive Review of.pdf - Published Version
Download (644kB)
Innovations in Pharmaceutical Therapeutics and Drug Delivery.pdf
Download (4MB)
Abstract
Fragile X syndrome (FXS) is the most common inherited single-gene cause of intellectual disability and a significant genetic cause of autism spectrum disorder. The disorder exhibits variable expressivity and reduced penetrance, particularly in females due to X-chromosome inactivation.
Clinically, FXS is associated with intellectual disability, behavioral problems, anxiety, and autism-related features. Diagnosis is primarily performed using molecular genetic techniques such as polymerase chain reaction (PCR) and Southern blot analysis to detect CGG repeat expansion and methylation status in the FMR1 gene. This chapter presents a comprehensive overview of the etiology, pathophysiology, diagnosis, and management of Fragile X syndrome.
| Item Type: | Book Section |
|---|---|
| Subjects: | Pharmacy Practice > Pathophysiology |
| Domains: | Pharmacy Practice |
| Depositing User: | Mr IR Admin |
| Date Deposited: | 11 May 2026 09:12 |
| Last Modified: | 11 May 2026 11:21 |
| URI: | https://ir.vistas.ac.in/id/eprint/17003 |
